Brookline Capital Markets
Affiliates

Track Record

Transactions

The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.

Featured Transactions

  1. April 2025Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering.
  2. September 2025Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor.
  3. July 2026Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.

Selected Client Transactions

Transaction results

  • Aquestive Therapeutics

    $85,000,000

    Follow-OnCo-Manager

  • iBio

    $50,000,000

    Follow-OnFinancial Advisor

  • Palisade Bio

    Completed EngagementCapital Markets Advisor

  • OS Therapies

    $4,200,000

    Warrant InducementCo-Solicitation Agent

  • Pyrophyte Acquisition Corp. II

    $175,000,000

    IPOCo-Manager

  • I-Mab

    Completed EngagementCapital Markets Advisor

  • TuHURA Biosciences

    $12,500,000

    PIPEFinancial Advisor

  • Quince Therapeutics

    $11,500,000

    PIPECo-Placement Agent

  • Forte Biosciences

    $75,000,000

    Follow-OnCo-Manager

  • Sonendo

    $5,000,000

    PIPEExclusive Placement Agent

  • Imunon

    $3,250,000

    PIPECo-Placement Agent

  • Immunic

    $65,000,000

    Follow-OnCo-Manager

  • Medicus Pharma

    $7,000,000

    Follow-OnCo-Placement Agent

  • Carmell

    $2,000,000

    ATMSole Sales Agent

  • Alcyone Therapeutics

    $14,200,000

    Series F Convertible Preferred StockExclusive Placement Agent

  • iOncologi

    $3,000,000

    Convertible NoteExclusive Placement Agent

  • Aquestive Therapeutics

    Completed EngagementCapital Markets Advisor

  • Scientific Industries

    $1,550,000

    PIPEExclusive Placement Agent

  • Intensity Therapeutics

    $2,350,000

    Follow-OnCo-Placement Agent

  • Stim.io

    $1,400,000

    Secondary SaleFinancial Advisor to Investor

  • Medicus Pharma

    $4,200,000

    Follow-OnCo-Placement Agent

  • Imunon

    Completed EngagementCapital Markets Advisor

  • NAYA Biosciences

    $9,500,000

    Follow-OnCo-Placement Agent

  • CASI Pharmaceuticals

    Completed EngagementCapital Markets Advisor